Repositorio Dspace

Listar por autor "Vagace, José-Manuel"

Listar por autor "Vagace, José-Manuel"

Ordenar por:Orden:Resultados:

  • Moreno, Celia; Ramos-Elbal, Eduardo; Velasco, Pablo; Aguilar, Yurena; Martínez, Berta-Gonzaalez; Fuentes, Carolina; Molinos, Agueda; Guerra-García, Pilar; Palomo, Pilar; Verdú, Jaime; Adán-Pedroso, Rosa-María; Vagace, José-Manuel; López-Duarte, Mónica; Regueiro, Alexandra; Tasso, María; Dapena, José-Luis; Salinas, José-Antonio; Navarro, Samuel; Bautista, Francisco; Lassaletta, Álvaro; Lendinez, Francisco; Rives, Susana; Pascual, Antonia; Rodríguez, Antonia; Pérez-Hurtado, José-María; Fernández, José-María; Pérez-Martínez, Antonio; González-Vicent, Marta; Díaz-de-Heredia, Cristina; Fuster-Soler, José-Luis (FRONTIERS MEDIA SA, 2023-03)
    INTRODUCTION: Studies addressing the role of haploidentical as alternative to HLA-matched donors for stem cell transplantation (SCT) often include patients with diverse hematological malignancies in different remission ...
  • Vega-García, Nerea; Pérez-Jaume, Sara; Esperanza-Cebollada, Elena; Vicente-Garces, Clara; Torrebadell, Montserrat; Jiménez-Velasco, Antonio; Ortega, Margarita; Llop, Marta; Abad, Lorea; Vagace, José-Manuel; Minguela-Puras, Alfredo; Pratcorona, Marta; Sánchez-García, Joaquín; García-Calderón, Clara-B; Gómez-Casares, María-Teresa; Martín-Clavero, Estela; Escudero, Adela; Rinon-Martínez-Gallo, Marta; Muñoz, Luz; Rosario-Velasco, María; García-Morin, Marina; Catala, Albert; Pascual, Antonia; Velasco, Pablo; Fernández, José-María; Lassaletta, Álvaro; Fuster, José-Luis; Badell, Isabel; Molinos-Quintana, Agueda; Molines, Antonio; Guerra-García, Pilar; Pérez-Martínez, Antonio; García-Abos, Miriam; Robles-Ortiz, Reyes; Pisa, Sandra; Adan, Rosa; Díaz-de-Heredia, Cristina; Dapena, José-Luis; Rives, Susana; Ramírez-Orellana, Manuel; Camos, Mireia (FRONTIERS MEDIA SA, 2021-02)
    Robust and applicable risk-stratifying genetic factors at diagnosis in pediatric T-cell acute lymphoblastic leukemia (T-ALL) are still lacking, and most protocols rely on measurable residual disease (MRD) assessment. In ...